Unitedhealth (UNH) EBITDA Margin (2009 - 2026)

Unitedhealth (UNH) has reported EBITDA Margin for 18 consecutive years, with 7.13% the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBITDA Margin rose 252.0% year-over-year to 7.13% in Q2 2026; TTM through Jun 2026 was 4.82%, a 246.0% decrease from a year earlier, with the FY2025 full-year figure at 4.46%, down 386.0% from the prior year.
• EBITDA Margin was 7.13% for Q2 2026 at Unitedhealth, down from 8.05% in the prior quarter.
• Over five years, EBITDA Margin peaked at 9.23% in Q3 2023 and troughed at 0.34% in Q4 2025.
• A 5-year average of 7.47% and a median of 8.23% in 2023 frame the typical range for EBITDA Margin.
• Across the five-year window, EBITDA Margin tumbled 738 bps in 2025 and jumped 252 bps in 2026, its largest moves.
• Over 5 years, EBITDA Margin stood at 8.32% in 2022, then declined by 2 bps to 8.14% in 2023, then decreased by 5 bps to 7.71% in 2024, then slumped by 96 bps to 0.34% in 2025, then jumped by 2025 bps to 7.13% in 2026.
• The last three EBITDA Margin figures came in at 7.13% (Q2 2026), 8.05% (Q1 2026), and 0.34% (Q4 2025), per Business Quant data.